New hope for lupus patients with kidney damage
NCT ID NCT07201129
Summary
This study is testing whether adding the experimental drug cenerimod to standard treatment helps adults with lupus nephritis, a serious kidney complication of lupus. About 300 participants will take either cenerimod or a placebo pill daily for about 1.5 years, alongside their regular medications. Researchers will check if cenerimod improves kidney function and is safe compared to the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS ERYTHEMATOSUS, SYSTEMIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Allied Biomedical Research Institute
RECRUITINGMiami, Florida, 33155, United States
-
Northwest Houston Arthritis
RECRUITINGHouston, Texas, 77090, United States
-
ProfessionalResearchCenter INC
RECRUITINGMiami, Florida, 33172, United States
-
Rheumatology Care Center, PLLC
RECRUITINGBellaire, Texas, 77401, United States
-
San Marcus Research Clinic, Inc.
RECRUITINGMiami Lakes, Florida, 33014, United States
-
SouthCoast Research Center
RECRUITINGMiami, Florida, 33136, United States
Conditions
Explore the condition pages connected to this study.